Daavlin 1 Series User Manual

MNL-00007 [3] Proprietary and Confidential Page 47 of 63
UVA, Skin Type III, 3/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
SECONDARY
DOSE (JOULES)
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
UVA, Skin Type III, 2/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
5.0
6.5
8.0
9.5
11.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
SECONDARY
DOSE (JOULES)
2.0
3.0
4.0
5.0
5.5
6.0
6.50
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
26.2 UVA Clearing Phase Protocols (Skin Types IV - VI)
Maximum Number of Treatments = 25
UVA, Skin Type IV, 11011
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
3.5
4.5
4.5
5.5
5.5
6.5
6.5
7.5
7.5
8.5
8.5
9.5
9.5
10.5
10.5
11.5
11.5
12.5
12.5
13.5
13.5
14.0
14.0
14.0
SECONDARY
DOSE (JOULES)
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
UVA, Skin Type IV, 3/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
4.5
5.5
6.5
7.5
8.5
9.5
10.5
11.5
12.5
13.5
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
SECONDARY
DOSE (JOULES)
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0

Daavlin 1 Series Specifications

General

Brand	Daavlin
Model	1 Series
Category	Medical Equipment
Language	English